A Subset of Rosai-Dorfman Disease Exhibits Features of IgG4-Related Disease
Authors:
Open Access
- 1 May 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 139 (5) , 622-632
Abstract
In this study we investigated the distribution of IgG4+ plasma cells and regulatory T (TREG) cells, a major regulator of IgG4 production, in nodal and extranodal Rosai-Dorfman disease (RDD). Twenty-six specimens (15 nodal, 11 extranodal) were examined, with reactive lymph nodes and site-matched extranodal specimens as controls. Overall, 84.6% (22/26) of the specimens showed various degrees of sclerosis (7 mild, 8 moderate, and 7 severe). Nineteen cases (73.1%) exhibited more than 10 IgG4+ cells/0.060 mm2 (photographed area at ×40), and 8 cases (30.8%) showed more than 40% of IgG+ cells being IgG4+. Only 1 control case exhibited more than 10 IgG4+ cells/0.060 mm2 (P < .05). The number of TREG cells was comparable between nodal RDD and controls, whereas extranodal RDD exhibited significantly higher numbers of TREG cells than controls. These findings demonstrate that a subset of RDD shows features of IgG4-related disease and indicate an overlap between certain aspects of the 2 diseases.Keywords
This publication has 25 references indexed in Scilit:
- Consensus statement on the pathology of IgG4-related diseaseLaboratory Investigation, 2012
- Autoimmune pancreatitis and IgG4-related sclerosing diseaseNature Reviews Gastroenterology & Hepatology, 2010
- IgG4+ Rosai–Dorfman disease of the lungHistopathology, 2010
- Distinctive Pulmonary Histopathology With Increased IgG4-positive Plasma Cells in Patients With Autoimmune PancreatitisAmerican Journal of Surgical Pathology, 2009
- IgG4‐positive plasma cells in cutaneous Rosai‐Dorfman disease: an additional immunohistochemical feature and possible relationship to IgG4‐related sclerosing diseaseJournal of Cutaneous Pathology, 2009
- Extranodal Rosai-Dorfman disease with bilateral orbital involvement: Report of a case treated with systemic steroid aloneClinical Ophthalmology, 2008
- Usefulness of oral corticosteroid in Rosai?Dorfman diseaseEuropean Journal of Cancer Care, 2007
- Regression of intracranial Rosai–Dorfman disease following corticosteroid therapyJournal of Neurosurgery, 2006
- Sinus histiocytosis with massive lymphadenopathy (SHML) prednisone resistant but dexamethasone sensitivePediatric Blood & Cancer, 2004
- Steroid-Responsive Rosai-Dorfman DiseasePediatric Hematology and Oncology, 1996